Pro Share Advisors LLC Neurocrine Biosciences Inc Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 8,083 shares of NBIX stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,083
Previous 8,745 7.57%
Holding current value
$1.11 Million
Previous $967,000 4.96%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$87.54 - $128.18 $57,951 - $84,855
-662 Reduced 7.57%
8,083 $1.02 Million
Q1 2025

May 08, 2025
SELL
$107.22 - $153.29 $84,382 - $120,639
-787 Reduced 8.26%
8,745 $967,000
Q4 2024

Feb 13, 2025
SELL
$111.62 - $139.44 $1.25 Million - $1.56 Million
-11,206 Reduced 54.04%
9,532 $1.3 Million
Q3 2024

Nov 13, 2024
BUY
$114.58 - $153.15 $1.12 Million - $1.5 Million
9,780 Added 89.25%
20,738 $2.39 Million
Q2 2024

Aug 13, 2024
SELL
$130.86 - $143.19 $113,979 - $124,718
-871 Reduced 7.36%
10,958 $1.51 Million
Q1 2024

May 08, 2024
BUY
$130.4 - $143.74 $49,943 - $55,052
383 Added 3.35%
11,829 $1.63 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $22,486 - $28,145
-212 Reduced 1.82%
11,446 $1.51 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $33,377 - $41,570
-355 Reduced 2.96%
11,658 $1.31 Million
Q2 2023

Aug 10, 2023
SELL
$89.53 - $104.87 $38,408 - $44,989
-429 Reduced 3.45%
12,013 $1.13 Million
Q1 2023

May 11, 2023
SELL
$94.11 - $123.02 $271,883 - $355,404
-2,889 Reduced 18.84%
12,442 $1.26 Million
Q4 2022

Feb 02, 2023
BUY
$106.72 - $127.06 $57,095 - $67,977
535 Added 3.62%
15,331 $1.83 Million
Q3 2022

Nov 04, 2022
BUY
$92.03 - $107.81 $49,144 - $57,570
534 Added 3.74%
14,796 $1.57 Million
Q2 2022

Aug 01, 2022
SELL
$75.79 - $100.07 $381,526 - $503,752
-5,034 Reduced 26.09%
14,262 $1.39 Million
Q1 2022

May 10, 2022
SELL
$72.45 - $94.81 $362,684 - $474,618
-5,006 Reduced 20.6%
19,296 $1.81 Million
Q4 2021

Feb 08, 2022
SELL
$79.65 - $106.22 $374,195 - $499,021
-4,698 Reduced 16.2%
24,302 $2.07 Million
Q3 2021

Nov 12, 2021
BUY
$86.18 - $99.03 $125,133 - $143,791
1,452 Added 5.27%
29,000 $2.78 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $497,141 - $568,518
5,559 Added 25.28%
27,548 $2.68 Million
Q1 2021

May 14, 2021
BUY
$87.57 - $119.4 $516,050 - $703,624
5,893 Added 36.61%
21,989 $2.14 Million
Q4 2020

Feb 09, 2021
SELL
$86.91 - $108.33 $47,192 - $58,823
-543 Reduced 3.26%
16,096 $1.54 Million
Q3 2020

Nov 13, 2020
BUY
$96.16 - $135.15 $29,040 - $40,815
302 Added 1.85%
16,639 $1.6 Million
Q2 2020

Aug 03, 2020
BUY
$85.09 - $130.36 $168,308 - $257,852
1,978 Added 13.78%
16,337 $1.99 Million
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $582,553 - $882,322
-7,756 Reduced 35.07%
14,359 $1.24 Million
Q4 2019

Feb 12, 2020
SELL
$86.8 - $118.57 $418,983 - $572,337
-4,827 Reduced 17.92%
22,115 $2.38 Million
Q3 2019

Nov 12, 2019
SELL
$83.82 - $101.5 $160,934 - $194,880
-1,920 Reduced 6.65%
26,942 $2.43 Million
Q2 2019

Aug 13, 2019
SELL
$72.24 - $91.27 $407,289 - $514,580
-5,638 Reduced 16.34%
28,862 $2.44 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $76,171 - $100,591
1,099 Added 3.29%
34,500 $3.04 Million
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $456,650 - $831,222
-6,684 Reduced 16.67%
33,401 $2.39 Million
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $16,315 - $20,765
165 Added 0.41%
40,085 $4.93 Million
Q2 2018

Aug 13, 2018
SELL
$75.3 - $105.99 $273,037 - $384,319
-3,626 Reduced 8.33%
39,920 $3.92 Million
Q1 2018

May 14, 2018
SELL
$75.88 - $92.43 $494,585 - $602,458
-6,518 Reduced 13.02%
43,546 $3.61 Million
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $101,022 - $133,920
-1,726 Reduced 3.33%
50,064 $3.88 Million
Q3 2017

Nov 13, 2017
BUY
$47.97 - $61.28 $227,233 - $290,283
4,737 Added 10.07%
51,790 $3.17 Million
Q2 2017

Aug 11, 2017
BUY
N/A
47,053
47,053 $2.16 Million

Others Institutions Holding NBIX

# of Institutions
658
Shares Held
102M
Call Options Held
290K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email